BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34780122)

  • 1. Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended-release tacrolimus preparation.
    El-Nahhas T; Popoola J; MacPhee I; Johnston A
    Clin Transl Sci; 2022 Jan; 15(1):70-78. PubMed ID: 34780122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited sampling strategies for tacrolimus exposure (AUC0-24) prediction after Prograf(®) and Advagraf(®) administration in children and adolescents with liver or kidney transplants.
    Almeida-Paulo GN; Lubomirov R; Alonso-Sanchez NL; Espinosa-Román L; Fernández Camblor C; Díaz C; Muñoz Bartola G; Carcas-Sansuán AJ
    Transpl Int; 2014 Sep; 27(9):939-48. PubMed ID: 24861353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients.
    Delaloye JR; Kassir N; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Labbé L; Théorêt Y; Litalien C
    Ther Drug Monit; 2011 Aug; 33(4):380-6. PubMed ID: 21743386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.
    Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
    Ther Drug Monit; 2008 Feb; 30(1):52-9. PubMed ID: 18223463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
    Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
    Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A limited sampling strategy to estimate exposure of once-daily modified release tacrolimus in renal transplant recipients using linear regression analysis and comparison with Bayesian population pharmacokinetics in different cohorts.
    Stifft F; Vandermeer F; Neef C; van Kuijk S; Christiaans MHL
    Eur J Clin Pharmacol; 2020 May; 76(5):685-693. PubMed ID: 32020321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique.
    van Boekel GA; Donders AR; Hoogtanders KE; Havenith TR; Hilbrands LB; Aarnoutse RE
    Eur J Clin Pharmacol; 2015 Jul; 71(7):811-6. PubMed ID: 25980838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Limited Sampling Strategies for the Estimation of Tacrolimus Area Under the Curve in Adult Kidney Transplant Recipients According to the Posttransplantation Time.
    Aouam K; Chadli Z; Hammouda M; Fredj NB; Aloui S; May ME; Boughattas N; Skhiri H; Chaabane A
    Ther Drug Monit; 2015 Aug; 37(4):524-30. PubMed ID: 25627405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically useful limited sampling strategy to estimate area under the concentration-time curve of once-daily tacrolimus in adult Japanese kidney transplant recipients.
    Nakazawa R; Yoshiike M; Nozawa S; Aida K; Katsuoka Y; Fujimoto E; Yazawa M; Kikuchi E; Shibagaki Y; Sasaki H
    PLoS One; 2019; 14(12):e0225878. PubMed ID: 31825991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Bayesian Forecasting Methods for Prediction of Tacrolimus Exposure Using Samples Taken on Two Occasions in Adult Kidney Transplant Recipients.
    Brooks E; Tett SE; Isbel NM; McWhinney B; Staatz CE
    Ther Drug Monit; 2021 Apr; 43(2):238-246. PubMed ID: 32932413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
    Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients.
    Barraclough KA; Isbel NM; Kirkpatrick CM; Lee KJ; Taylor PJ; Johnson DW; Campbell SB; Leary DR; Staatz CE
    Br J Clin Pharmacol; 2011 Feb; 71(2):207-23. PubMed ID: 21219401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a 2-Point Limited Sampling Strategy to Predict the Tacrolimus Area-Under-the-12-Hour-Curve in Kidney Transplant Recipients.
    Vadcharavivad S; Susomboon T; Kulabusaya B; Avihingsanon Y; Praditpornsilpa K; Townamchai N
    Ther Drug Monit; 2016 Oct; 38(5):614-20. PubMed ID: 27328329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.
    Saint-Marcoux F; Debord J; Undre N; Rousseau A; Marquet P
    Ther Drug Monit; 2010 Apr; 32(2):129-35. PubMed ID: 20110850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Multiple Linear Regression-Based Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients.
    Brooks EK; Tett SE; Isbel NM; McWhinney B; Staatz CE
    Ther Drug Monit; 2018 Apr; 40(2):195-201. PubMed ID: 29461443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
    Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
    Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients.
    Wang XH; Shao K; An HM; Zhai XH; Zhou PJ; Chen B
    Eur J Clin Pharmacol; 2022 Aug; 78(8):1261-1272. PubMed ID: 35536394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients.
    Barraclough KA; Isbel NM; Franklin ME; Lee KJ; Taylor PJ; Campbell SB; Petchey WG; Staatz CE
    Ther Drug Monit; 2010 Dec; 32(6):723-33. PubMed ID: 21068647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
    Poulin E; Greanya ED; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
    Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited Sampling Strategy for the Estimation of Tacrolimus Area Under the Concentration-Time Curve in Chinese Adult Liver Transplant Patients.
    Liu XX; Xu BM; Chen H; Song YY; Yang WH; Chen B
    Pharmacology; 2016; 98(5-6):229-241. PubMed ID: 27449772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.